Subscribe for Updates

Berkley Renewables Inc. is a growth-oriented venture firm pursuing opportunities in Renewable Energy, Life Sciences and the Oil & Gas sectors. The company is currently pursuing unique solar energy investments in Ontario, Canada. Berkley has diversified by purchasing an equity interest in RepliCel Life Sciences Inc., a publicly-traded, regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
April 21, 2015
RepliCel Given Green Light for Clinical Trial of Achilles Injury Treatment
April 6, 2015
Berkley issues Q1 2015 Newsletter
March 2, 2015
RepliCel submits clinical trial application for its Dermatological Clinical Trial
February 12, 2015
RepliCel's RCT-01 treatment has significant implications for athletes
January 20, 2015
Our solar and life science interests are heading into the New Year with exciting developments on the horizon.
Tue Sep 30, 2014
2014 Q3